October 18, 2026 09:38 am (IST)

Make this your homepage

Health

'Internet access a fundamental right for children': SC rejects age-based 'blanket' ban | 'We will fight our own government': RG Kar victim's father threatens fresh protest after Sandip Ghosh gets bail | RG Kar shocker: Sandip Ghosh gets bail as only 7 of 147 witnesses examined, junior doctor blasts CBI | Trump waives Russia-related sanctions | 'How dare Elon Musk?' Owaisi defends Modi after billionaire's 'real boss' jibe at Ambani | 'B****y S***': IAS officer's abuse of female colleague during virtual J&K meeting sparks row | Aamir Khan’s nephew Imran Khan asked to leave India by Oct 28 after joining anti-CEC protest | ‘Their crime? Demanding justice’: Rahul Gandhi slams 4 AM detention of Ankita Bhandari’s parents | ‘Bangladesh showed us the way’: Neha Bora’s remarks spark BJP attack on Rahul Gandhi | Chingrighata flyover skid scare: Bikes fall, anti-skid blocks installed overnight as Bengal Minister Agnimitra Paul faces criticism

Government to roll out new drug for treatment of drug-resistant TB

India Blooms News Service | | Mar 21, 2016, at 08:09 pm

New Delhi, Mar 21 (IBNS) The central government is launching a drug called Bedaquiline on Monday for the treatment of multi-drug resistant tuberculosis (MDR TB) and extensively drug resistant tuberculosis (XDR TB), according to media reports.

Dubbed a 'miracle drug', Bedaquiline (trade name Sirturo) is the first TB drug to be approved by Food and Drug Administration (FDA) in over 40 years.

The project is part of a coordinated programme between the government and Johnson & Johnson and has been rolled out under the Revised National Tuberculosis Control Programme; Janssen, a pharma unit under Johnson & Johnson has manufactured the drug.

The drug will be made available in six public hospitals in Delhi, Mumbai, Chennai, Guwahati and Ahmedabad, according to reports.

In an exclusive interview to Times of India, Sanjiv Navangul, Janssen India MD, said, "We are ready with the roll-out of the drug through the government-run control programme, for which 600 patients will be enrolled across the country, over the next six to nine months, after the required tests. Upon the review of clinical data after two years, the access programme will be expanded nationwide."

As per World Health Organisation (WHO) Global Tuberculosis Report 2015, deaths due to TB were estimated in India to be 2,20,000 in 2014, which is higher than any other country.

#Food and Drug Administration # World Health Organisation # Johnson & Johnson

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.

India
International

Related Images

CMRI Hospital celebrates Patients' Experience Week with Walkathon Oct 09, 2025, at 06:21 pm

Kolkata: BITM hosts an interactive session with students to observe Shubhanshu Shukla's return to Earth Jul 16, 2025, at 07:45 pm

West Bengal government airlifts ailing Gangasagar pilgrims to Kolkata Jan 13, 2025, at 12:45 pm